Rockville | Maryland Clinical Trials | U.S. Dermatology Partners

Menu

U.S. Dermatology Partners Rockville

15245 Shady Grove Rd
#480
Rockville, MD 20850

(301) 681-7397

Meet the Doctors

Benjamin Lockshin, MD

Janet Lin, MD

Amy Cole, MD

Ashley DiLorenzo, MD

Rockville Clinical Trials

Alopecia Areata

Atopic Dermatitis

Atopic Dermatitis (Corrona Registry)

Corrona Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

Moderate-to-Severe Atopic Dermatitis Study (2-11 Years)

A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis Study Description Upadacitinib is an approved drug for treating AD patients aged 12 or older. Participants will receive upadacitinib (given as daily dose) ...

Moderate-to-Severe Atopic Dermatitis Study (12 Years+)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults Study Description Treatment with nemolizumab will be determined solely by the participant’s physician prior to study enrollment. No additional visits, procedures, or laboratory tests are required outside of routine clinical practice. The visit structure is not defined by the study ...

Psoriasis

Moderate-to-Severe Psoriasis Study (12-17 Years)

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis Study Description Brief Summary The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) ...

Skin Cancer

Cutaneous Squamous Cell Carcinoma Study (18 Years+)

A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) Study Description This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer. Cemiplimab works by helping the ...

Prurigo Nodularis

Prurigo Nodularis Study (18-75 Years)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis Study Description Brief Summary The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis. Condition or Disease Prurigo Nodularis Study Design Study Type: Interventional (Clinical Trial) ...